Denmark study finds no increased risk of 28 adverse events following vaccination with a monovalent XBB.1.5-containing vaccine given as a fifth dose to adults 65 years or older.
Study evaluates efficacy of one and two doses of recombinant zoster vaccine overall, by time since vaccination, age and immunocompromise status, and with a late second dose.
Dr. Robert Dickson notes that in helping geriatric patients, younger doctors may need to familiarize themselves with out-of-fashion vocabulary—such as the term used by an older woman who suffered for fashion years ago.